Equities

AroCell AB (publ)

AroCell AB (publ)

Actions
  • Price (EUR)0.052
  • Today's Change-0.001 / -1.89%
  • Shares traded0.00
  • 1 Year change+44.44%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in SEKIncome statement in SEKView more

Year on year AroCell AB (publ) grew revenues 16.37% from 36.99m to 43.04m while net income improved from a loss of 58.97m to a smaller loss of 59.30m.
Gross margin8.63%
Net profit margin-111.28%
Operating margin-113.36%
Return on assets--
Return on equity--
Return on investment--
More ▼

Cash flow in SEKView more

In 2023, cash reserves at AroCell AB (publ) fell by 14.47m. Cash Flow from Financing totalled 250.00k or 0.58% of revenues. In addition the company used 13.44m for operations while cash used for investing totalled 1.28m.
Cash flow per share-0.1472
Price/Cash flow per share--
Book value per share0.608
Tangible book value per share0.238
More ▼

Balance sheet in SEKView more

AroCell AB (publ) appears to have little financial risk as the company holds a substantial amount of cash on its books with little or no debt.
Current ratio5.08
Quick ratio4.61
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.